Efficacy of Yoga Based Self-Management Program for Chronic Pain

November 9, 2020 updated by: Aarogyam UK

Efficacy of Yoga Based Self-Management Program for Chronic Pain: Community Based Clinical Efficacy Study

Chronic pain is a major health issue with substantial economic burden.To support chronic pain patients during the COVID-19 pandemic, yoga based self-managed intervention was delivered through tele-health platform. Project was designed as community-based program, creating new social networks for patients, health care providers and academics. Platform to deliver intervention and data collection was AiM COVID mobile app.

Our objective was to determine the efficacy of Yoga based self-management intervention for people living with chronic pain pain intensity, disability and health related quality of life.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

42

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Leicestershire
      • Leicester, Leicestershire, United Kingdom
        • Aarogyam UK
    • Scotland
      • Glasgow, Scotland, United Kingdom
        • Patanjali Yog Peeth (UK) Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Community based project in partnership with community organisation, health care providers and academic included chronic pain patients for yoga self management therapy.

Description

Inclusion Criteria:

  • Chronic pain for at least 3 months
  • Having access to internet and video calls

Exclusion Criteria:

  • Pregnant or breast-feeding women,
  • Patients not willing to give written consent
  • Patients with severe psychiatric or personality disorder
  • Malignancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity and disability
Time Frame: From baseline to 6 week post intervention
Pain intensity and related disability was measured through Brief Pain Inventory
From baseline to 6 week post intervention
Health Related Quality of Life
Time Frame: From baseline to 6 week post intervention
Quality of life was measured through 36-Item Short-Form Survey
From baseline to 6 week post intervention
Self-efficacy of pain
Time Frame: From baseline to 6 week post intervention
Self efficacy was measure through Pain Self-Efficacy Questionnaire
From baseline to 6 week post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Neha Sharma, Aarogyam UK
  • Study Chair: Deepa Modi, East Park Medical Centre, NHS trust, Leicester
  • Study Director: Vishwesh Kulkarni, University of Warwick
  • Principal Investigator: Sunita Poddar, Patanjali Yog Peeth (UK) Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 17, 2020

Primary Completion (Actual)

November 5, 2020

Study Completion (Actual)

November 9, 2020

Study Registration Dates

First Submitted

November 9, 2020

First Submitted That Met QC Criteria

November 9, 2020

First Posted (Actual)

November 13, 2020

Study Record Updates

Last Update Posted (Actual)

November 13, 2020

Last Update Submitted That Met QC Criteria

November 9, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AU0211

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Yoga Therapy

3
Subscribe